Lv2
158 积分 2025-03-06 加入
Chronic fatigue and physical distress influence the outcomes of immunotherapy treatment in patients with recurrent ovarian cancer
1个月前
已关闭
Chronic fatigue and physical distress influence the outcomes of immunotherapy treatment in patients with recurrent ovarian cancer
1个月前
已完结
Associations between psychosocial risk factors and immune checkpoint inhibitor outcomes
1个月前
已关闭
P4.15D.04 Association Between Emotional Distress and Immunotherapy Response in Advanced NSCLC (STRESS-LUNG-1): Biomarkers Exploratory Analyses
1个月前
已完结
The association between emotional distress prior to receiving immune checkpoint inhibitors and overall survival among patients with cancer: A population-based study
1个月前
已关闭
Phase 2 Study of Telomelysin (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
2个月前
已关闭
837P Phase II trial of oncolytic vaccinia virus primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588)
2个月前
已完结
Relationship of infusion duration to safety, efficacy, and pharmacodynamics (PD): Second part of a phase I-II study using VSV-IFNβ-NIS (VV1) oncolytic virus in patients with refractory solid tumors
2个月前
已关闭
A phase II trial of stereotactic radiation therapy and in situ oncolytic virus therapy in metastatic triple-negative breast cancer (mTNBC) patients followed by pembrolizumab (STOMP)
2个月前
已关闭
皖公网安备34019202002308
